Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: Whitmore G. who wrote (5655)	7/22/2023 10:37:53 PM
From: Gary Mohilner	Read Replies (1) \| Respond to of 5665

I believe if we give it time we'll be worth more than that. To achieve an offer of $50 all that's actually needed is reaching a share price of $25 or more, so if you're right it may come later this year. I believe that Pivek data, which should be coming at conferences later this year, could send us well above $25 and perhaps raise your thinking on a buyout to $60 or more. I believe out technology superior to that of SGEN and would be disappointed after all this time if we failed to get at least half what's being offered for SGEN. Clearly they have more approved drugs, but ours once approved may be bigger selling and our technology should have more to offer in developing of future products. Gary